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Purpose. To evaluate macular retinal ganglion cell-inner plexiform layer (GCIPL) thickness changes after Brilliant Blue G-assisted
internal limiting membrane peeling for idiopathic macular hole repair using a high-resolution spectral-domain optical coherence
tomography (SD-OCT).Methods. 32 eyes from 32 patients with idiopathic macular holes who underwent vitrectomy with internal
limiting membrane peeling between January 2011 and July 2012 were retrospectively analyzed. GCIPL thickness was measured
before surgery, and at one month and at six months after surgery. Values obtained from automated and semimanual SD-OCT
segmentation analysis were compared (Cirrus HD-OCT, Carl Zeiss Meditec, Dublin, CA). Results. No significant differences were
found between average GCIPL thickness values between preoperative and postoperative analysis. However, statistical significant
differences were found in GCIPL thickness at the temporal macular quadrants at six months after surgery. Quality measurement
analysis performed by automated segmentation revealed a significant number of segmentation errors. Semimanual segmentation
slightly improved the quality of the results. Conclusion. SD-OCT analysis of GCIPL thickness found a significant reduction at the
temporal macular quadrants at 6 months after Brilliant Blue G-assisted internal limiting membrane peeling for idiopathic macular
hole.
1. Introduction
Nowadays, one of the most common surgical procedures
for idiopathic macular hole (IMH) management is based on
vitrectomy with internal limiting membrane (ILM) peeling
[1–3]. Different vital dyes such as indocyanine green (ICG)
or Brilliant Blue G (BBG) and other substances such as
triamcinolone acetonide (TA) have been used to assist in
peeling of the ILM of the neuroretina [4–6]. However, several
authors have reported histological and functional damage
to the retina after IMH surgery with ICG-assisted ILM
peeling [3, 7–10]. In contrast, BBG or TA appears to be safer
alternatives for ILM peeling [6, 11, 12].
On the other hand, ILM peeling itself may induce visible
changes of the inner retinal surface, although no changes in
retinal nerve fiber layer (RNFL) thickness have been detected
[13]. However, there is some controversy about the effect
that BBG-assisted ILM peeling has on the retinal ganglion
cell complex (RGCC) [14, 15]. Moreover, a recent study has
suggested that ILM peelingmay reduce retinal sensitivity and
increase the incidence of microscotomas [16].
Hindawi Publishing Corporation
BioMed Research International
Volume 2014, Article ID 458631, 8 pages
http://dx.doi.org/10.1155/2014/458631
2 BioMed Research International
OSOD
500
400
300
200
100
0
(𝜇
m
)
Overlay: ILM-RPE Transparency: 50%
263
304
286
314
238
218284335281
ILM-RPE thickness (𝜇m) Fovea: 247, 65
ILM-RPE
ILM
RPE
Diversified:
distribution
of normals
99
(%
)95
5
1
ILM-RPE
Central
subfield
thickness
(𝜇m)
286
Cube
volume
(mm3)
9.4
Cube
average
thickness
(𝜇m)
261
Macula thickness: macular cube 512 × 128
(a)
OD thickness map OS thickness map
225
150
75
0
(𝜇
m
)
Fovea: 251, 64 Fovea: 247, 65
OD deviation map OD sectors
74
75
76
77
78
79
OD horizontal B-scan
OS deviation mapOS sectors
OS horizontal B-scan
67
62
54
71
77
77
Average GCL + IPL thickness
Minimum GCL + IPL thickness
76 68
77 57
OD (𝜇m) OS (𝜇m)
OSOD
Diversified:
distribution
of normals
(%
)95
5
1
(𝜇
m
)
(%
)
Ganglion cell OU analysis: macular cube 512 × 128
(b)
Figure 1: Macular analysis of the left eye and ganglion cell analysis of both eyes of a 78-year-old woman at 6 months after vitrectomy with
Brilliant BlueG-assisted internal limitingmembrane peeling for idiopathicmacular hole. (a)OCT cross-section analysis showing cube volume
and cube thickness. (b) Average, minimum, and sectorial macular thickness of the ganglion cell-inner plexiform layer of both eyes. Amacular
temporal defect may be appreciated in the left eye.
To our knowledge, only a few groups have evaluated the
effect of ILM peeling on the RGCC after idiopathic macu-
lar hole surgery using the RTVue-100 SD OCT (Optovue,
Fremont, CA, USA) with different results [14, 15, 17]. In the
current study, we evaluated for the first time the capacity
of the new ganglion cell analysis (GCA) software of the
Cirrus HD-OCT (Carl ZeissMeditec, Dublin, CA) to analyze
the retinal ganglion cell-inner plexiform layer (GCIPL) after
BBG-assisted internal limiting membrane peeling for idio-
pathic macular hole surgery. Additionally, we evaluated how
BBG-assisted ILM peeling affects the macular and average
GCIPL thickness at 1 and 6months aftermacular hole surgery
with this new software.
2. Materials and Methods
This study was a multicenter (𝑛 = 5), retrospective, and
observational study of 32 patients. The institutional review
board approval of every center was obtained. All of the
patients underwent a vitrectomy associated with BBG-
assisted peeling of the retinal ILM as a consequence of an
IMH between January 2011 and July 2012. Seven patients were
excluded for the following reasons: a history of glaucoma (1),
failure to correctly identify the limits of the GCIPL by the
ganglion cell analysis software by automated or semimanual
segmentation (4), or macular holes greater than the central
area of analysis where the GCA software does not measure
the GCIPL thickness (2) (Figure 1). Therefore, a total of 25
eyes of 25 patients were included in this study.
Demographic information collected from the clinical
chart included patient age, sex, combined cataract surgery,
macular hole stage, preoperative best-corrected visual acuity
(BCVA), postoperative BCVA, intraocular hypertension after
surgery (>25mmHg), history of glaucoma, and failure to
close the macular hole. Best-corrected visual acuity was
measured using a decimal visual acuity chart, and the decimal
visual acuity was converted to the logarithm of the minimum
angle of resolution (logMAR) units for statistical analysis.
Three-dimensional cube OCT data were obtained with
the Cirrus HD-OCT device using the Macular Cube 200 ×
200 scan protocol. This protocol performs 200 horizontal B-
scans comprising 200 A-scans per B-scan over 1024 samples
within a cube measuring 6 × 6 × 2mm. The GCA software
(6.0 version) evaluates the thickness of the ganglion cell plus
inner plexiform layers. The average, minimum, and sectorial
thicknesses of the GCIPL are measured in an elliptical annu-
lus (vertical inner and outer radius of 0.5mm and 2.0mm;
horizontal inner and outer radius of 0.6 and 2.4mm, resp.)
around the fovea. In order to avoid segmentation errors,
OCT measurements with signal strength (SS) below 5 were
excluded (0: lowest SS; 10: highest SS).
All OCT images were obtained by experienced clinical
technicians. Eyes were dilated with tropicamide 1% and
phenylephrine 2.5%. AverageGCIPL thickness, macular cube
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Figure 2: This example shows the relocation of the area of analysis
(semimanual segmentation). The center was manually displaced
following the direction of the black arrow (b).
average thickness (MCAT), andmacular cube volume (MCV)
values of the patients included in this study were measured
preoperatively, at 1 and at 6months aftermacular hole surgery
by scanning with the Cirrus HD-OCT system (Carl Zeiss
Meditec, Dublin, CA) (Figure 1).
The main outcome measure was the comparison of
average GCIPL thickness preoperatively and at 6 months
after macular hole surgery with BBG-assisted ILM peeling.
Comparison of MCAT and MCV preoperatively and at 6
months after macular hole surgery with ILM peeling was
the secondary outcome measures. Moreover, all values were
obtained at 1 month after surgery. Average, minimum, and
sectorial (superior, inferior, superonasal, inferonasal, super-
otemporal, and inferotemporal) GCIPL thickness values were
obtained and compared in every patient preoperatively and at
1 and 6 months after surgery (Figure 1).
Each GCIPL scan was evaluated in order to identify how
many cases had a greater GCIPL thickness after surgery
compared to before. This data was studied to evaluate the
quality of the measurements, as the real GCIPL thickness
should not be higher in the postoperative period.
A comparison between preoperative and postoperative
macular GCIPL thickness values was also performed by
semimanual segmentation. The Cirrus HD-OCT (Carl Zeiss
Meditec, Dublin, CA) GCIPL analysis software is not capable
of real manual segmentation of the macular layers, but it
does allow relocation of the area of analysis (Figure 2). This
procedure was performed in every scan by an experienced
clinical technician in order to improve the quality of the
measurements by repositioning the area of analysis in the real
center of the fovea.
Surgery was performed using a standard 23- or 25-
gauge 3-port pars plana vitrectomy. The infusion cannula
was placed in the inferotemporal quadrant. If the posterior
hyaloid was still attached to the optic disc, its detachment
was induced by suction with the vitrectomy probe. A volume
of 0.1mL BBG (Fluoron GmbH, Ludwigsfeld, Germany) at a
concentration of 0.25mg/mL was injected into the vitreous
cavity over the posterior pole for 30 seconds. The ILM was
grasped at the temporal quadrant and peeled off with forceps
Table 1: Demographic characteristics.
Parameter Values %
Sex
Male 11 44
Female 14 56
Age∗ 70.48 ± 8.66
Eye
Right 13 52
Left 12 48
Macular hole stage
2 6 24
3 8 32
4 11 44
Visual acuity (logMAR)
Preoperative∗ 0.70 ± 0.32
Postoperative∗ 0.34 ± 0.32
Glaucoma
No 25 100
Yes 0 0
Macular hole closure 25 100
∗Mean ± SD.
logMAR: logarithm of the minimum angle of resolution.
in an area of 2-disc diameter around the macular hole. Fluid-
air exchange and intraocular gas tamponade with SF6 at
20% were performed. After surgery, patients were asked to
remain in a facedown position for at least 50 minutes per
hour for four days. In 12 patients, the crystalline lens was
removed by phacoemulsification followed by intraocular lens
implantation before pars plana vitrectomy. A topical beta
blocker (timolol maleate 0.5%BID) was routinely used to
prevent postoperative intraocular pressure (IOP) rise.
The differences in the OCT values between the preopera-
tive time and at 1 and at 6 months after surgery were analyzed
using the paired t-test.The descriptive statistics are expressed
as the means, standard deviations (SDs), and percentages.
Visual acuity data were converted to the logarithm of the
minimal angle of resolution (logMAR). Statistical analysis
was performed using SPSS, version 15.0 (SPSS Inc., Chicago,
IL). A 𝑃 value of ≤0.05 was considered significant.
3. Results and Discussion
The study sample was comprised of 25 eyes of 25 participants
(mean age 70.48 ± 8.66 years old, range: 49–82). Mean
preoperative and postoperative (6 months) BCVA were 0.7
± 0.32 logMAR units and 0.34 ± 0.32 logMAR units, respec-
tively.The rate of closure of macular holes by OCT evaluation
was 100% at 1 and 6 months after surgery. Twelve patients
underwent a combined cataract surgery with pars plana
vitrectomy. None of the patients had a postoperative retinal
detachment. There was no recorded incidence of increased
postoperative IOP above 25mmHg. Demographic data are
shown in Table 1.
Average MCV was 10.22 ± 0.81 𝜇m at the preoperative
period, 10.03 ± 1.06𝜇m at 1 month after surgery, and 9.85
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Table 2: Comparison between preoperative and postoperative (at 1 month after surgery) macular GCIPL thickness values performed by
automated segmentation.
𝑁 = 25
Preoperative
(𝜇m) SD (𝜇m)
Postoperative
(𝜇m) SD (𝜇m)
Difference
(𝜇m) SD (𝜇m) 𝑃 value
∗
Average GCIPL thickness 60.72 18.20 61.52 17.37 −0.8 0.83 0.865
Minimum GCIPL thickness 33.56 18.20 43.60 23.83 −10.04 −5.63 0.134
GCIPL superior 59.76 26.37 64.04 27.73 −4.28 −1.36 0.531
GCIPL inferior 53.88 23.79 59.56 18.48 −5.68 5.31 0.363
GCIPL superonasal 59.04 24.77 65.64 22.01 −6.6 2.76 0.243
GCIPL superotemporal 69.48 14.87 59.20 20.37 10.28 −5.5 0.076
GCIPL inferonasal 54.48 20.62 62.80 18.90 −8.32 1.72 0.116
GCIPL inferotemporal 67.40 20.55 59.36 22.77 8.04 −2.22 0.176
∗Student’s 𝑡-test.
GCIPL: ganglion cell-inner plexiform layer.
SD: standard deviation.
Table 3: Comparison between preoperative and postoperative (at 1 month after surgery) macular GCIPL thickness values performed by
semimanual segmentation.
𝑁 = 25
Preoperative
(𝜇m) SD (𝜇m)
Postoperative
(𝜇m) SD (𝜇m)
Difference
(𝜇m) SD (𝜇m) 𝑃 value
∗
Average GCIPL thickness 69.23 19.50 65.00 14.80 4.23 4.70 0.466
Minimum GCIPL thickness 49.69 23.29 47.85 23.78 1.85 −0.50 0.832
GCIPL superior 66.31 21.64 63.15 19.27 3.15 2.37 0.610
GCIPL inferior 63.31 22.35 63.54 16.49 −0.23 5.86 0.973
GCIPL superonasal 71.08 25.08 68.69 23.15 2.38 1.93 0.728
GCIPL superotemporal 75.23 14.21 62.08 18.27 13.15 −4.06 0.083
GCIPL inferonasal 67.15 24.13 71.69 17.07 −4.54 7.06 0.303
GCIPL inferotemporal 72.00 19.20 61.46 17.16 10.54 2.03 0.198
∗Student’s 𝑡-test.
GCIPL: ganglion cell-inner plexiform layer.
SD: standard deviation.
± 0.95 𝜇m at 6 months after surgery. Additionally, MCAT
was 283.92 ± 21.86 𝜇m at the preoperative period, 279.8 ±
29.23 𝜇m at 1 month after surgery, and 274.64 ± 26.53𝜇m at
6 months after surgery. Statistically significant differences in
the average MCV and MCAT were found at 6 months after
surgery (𝑃 = 0.008 and 𝑃 = 0.016, resp.). In contrast, no
differences were found in the average MCV and MCAT at 1
month after surgery (𝑃 = 0.186 and 𝑃 = 0.318, resp.).
Preoperative and postoperative average GCIPL thickness
values obtained by automated segmentation were 60.72 ±
18.20 𝜇m and 61.52 ± 17.37 𝜇m, respectively, with no statisti-
cally significant differences between the two groups (Table 2).
Similarly, preoperative and postoperative average GCIPL
thickness obtained by semimanual segmentation was 69.23 ±
19.50 and 65.00 ± 14.80 𝜇m, respectively, and no statistically
significant differences were found either (Table 3). However,
automated segmentation analysis showed statistically signif-
icant differences in the GCIPL thickness at the superior-
temporal quadrant at 6 months after surgery (𝑃 = 0.026)
(Table 4). No differences were found in the comparison of
other GCIPL quadrants analyses. In contrast, when the analy-
sis was performed by semimanual segmentation, statistically
significant differences were found in the GCIPL thickness
at both the superotemporal and inferotemporal quadrants at
6 months after surgery (𝑃 = 0.011 and 𝑃 = 0.013, resp.)
(Table 5).
Quality measurement analysis performed by automated
segmentation showed that GCIPL thickness was higher in the
postoperative period in around 50% of the scans (Table 6).
Therefore, a significant number of segmentation errors can
be expected when the automated analysis is performed in
patients with macular holes. Similarly, the quality mea-
surement analysis performed by semimanual segmentation
revealed only a slight improvement in the GCIPL segmen-
tation (Table 7).
Nowadays, ILM peeling combined with pars plana vitrec-
tomy is considered an effective procedure for IMH surgery
[1]. The removal of ILM is associated with better anatomic
results and faster visual acuity recovery after surgery [1, 18,
19]. However, some adverse effects have been documented
after ILM peeling, which may be associated with the use
of vital dyes during surgery [20–23]. Recently, BBG-assisted
ILM peeling has been reported to be safer than other dyes
[24–26]. Still, a marked decrease of the average RGCC thick-
ness at 6 months after surgery has been recently documented
after ICG or BBG-assisted ILM peeling, with no differences
BioMed Research International 5
Table 4: Comparison between preoperative and postoperative (at 6 months after surgery) macular GCIPL thickness values performed by
automated segmentation.
𝑁 = 25
Pre-operative
(𝜇m) SD (𝜇m)
Postoperative
(6m) (𝜇m) SD (𝜇m)
Difference
(𝜇m) SD (𝜇m) 𝑃 value
∗
Average GCIPL thickness 60.72 18.20 61.20 14.71 −0.48 3.49 0.912
Minimum GCIPL thickness 33.56 18.20 44.20 19.38 −10.64 −1.18 0.053
GCIPL superior 59.76 26.37 58.32 19.46 1.44 6.91 0.808
GCIPL inferior 53.88 23.79 60.16 15.07 −6.28 8.72 0.292
GCIPL superonasal 59.04 24.77 64.28 20.28 −5.24 4.49 0.353
GCIPL superotemporal 69.48 14.87 59.52 14.83 9.96 0.04 0.026
GCIPL inferonasal 54.48 20.62 64.08 15.56 −9.6 5.06 0.080
GCIPL inferotemporal 67.40 20.55 60.72 17.31 6.68 3.24 0.070
∗Student’s 𝑡-test.
GCIPL: ganglion cell-inner plexiform layer.
SD: standard deviation.
Table 5: Comparison between preoperative and postoperative (at 6 months after surgery) macular GCIPL thickness values performed by
semimanual segmentation.
𝑁 = 25
Preoperative
(𝜇m) SD (𝜇m)
Postoperative
(6m) (𝜇m) SD (𝜇m)
Difference
(𝜇m) SD (𝜇m) 𝑃 value
∗
Average GCIPL thickness 69.23 19.50 63.77 10.14 5.46 9.36 0.241
Minimum GCIPL thickness 49.69 23.29 45.08 16.94 4.62 6.35 0.499
GCIPL superior 66.31 21.64 60.69 15.80 5.62 5.84 0.292
GCIPL inferior 63.31 22.35 62.31 14.40 1.00 7.95 0.866
GCIPL superonasal 71.08 25.08 67.85 17.23 3.23 7.85 0.590
GCIPL superotemporal 75.23 14.21 60.08 10.70 15.15 3.51 0.011
GCIPL inferonasal 67.15 24.13 72.54 11.13 −5.38 13.01 0.313
GCIPL inferotemporal 72.00 19.20 58.62 10.19 13.38 9.01 0.013
∗Student’s 𝑡-test.
GCIPL: ganglion cell-inner plexiform layer.
SD: standard deviation.
between both dyes [17]. In contrast, Sevim and Sanisoglu
showed no significant decrease of the average, superior, and
inferior RGCC thickness after BBG-assisted ILMpeeling [14].
The variables generated by the GCC measuring mode of
the original software of the RTVue-100 SD OCT (Optovue,
Fremont, CA, USA) employed by Baba et al. and Sevim et al.
include the average, superior (0–180 degrees), and inferior
(180–360 degrees) thickness of the RGCC, which comprises
the retinal nerve fiber layer, the ganglion cell layer, and the
inner plexiform layer. In contrast, the ganglion cell analysis
(GCA) software of the Cirrus HD-OCT (Carl Zeiss Meditec,
Dublin, CA) used in this study allows obtaining the GCIPL
thickness, and therefore the retinal nerve fiber layer is not
included in the measurement. Furthermore, GCA software
generates specific variables for each quadrant of the macular
area (superior, inferior, superonasal, inferonasal, superotem-
poral, and inferotemporal), as well as the average and min-
imum GCIPL thickness. Therefore, a more specific analysis
of the inner retinal thickness area may be performed with
this software. Actually, we observed no changes in the average
GCIPL thickness at 1 and 6months after surgery (Tables 3–6).
However, when the analysis was performed by semimanual
segmentation and individual macular quadrants, a focal
GCIPL thickness decrease in the superotemporal and infer-
otemporal macular area was seen at 6 months after surgery
(Table 5). Similarly, when the analysis was performed by
automated segmentation, a focal GCIPL thickness decrease
was observed in the superotemporal macular area.
Based on our results, we hypothesize that as the RNFL is
thinner at the temporal area than at the nasal area [27], the
ganglion cells may be more exposed to the retinal surface,
and consequently to the BBG dye, which could have some
toxic effects over these cells. Some in vitro studies have
found a significant decrease in cell viability in both retinal
pigment epithelial cells and retinal ganglion cells at exposure
times to BBG as early as 3 minutes [28–30]. This reduction
in cell viability has been attributed to a cytostatic effect
[31]. Additionally, the ILM peeling may cause a mechanical
damage over the ganglion cell layer, which is “less” protected
by the RNFL at the temporal area. On the other hand,
ILM was usually grasped and peeled off from the temporal
quadrant, which may contribute to the mechanical damage
at this area.
Several groups have reported nasal visual defects after
ICG-assisted ILM peeling in IMH surgery [8–10, 32]. Some
factors that may be responsible for this defect include ICG
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Table 6:Qualitymeasurement analysis between the preoperative and postoperativemacularGCIPL thickness values performed by automated
segmentation.
𝑁 = 25
Postoperative (1m) Postoperative (6m)
GCIPL (< or =)∗ GCIPL (>)† GCIPL (< or =)∗ GCIPL (>)†
Average GCIPL thickness 12 48% 13 52% 11 44% 14 56%
Minimum GCIPL thickness 9 36% 16 64% 9 36% 16 64%
GCIPL superior 11 44% 14 56% 12 48% 13 52%
GCIPL inferior 10 40% 15 60% 10 40% 15 60%
GCIPL superonasal 14 56% 11 44% 12 48% 13 52%
GCIPL superotemporal 15 60% 10 40% 18 72% 7 28%
GCIPL inferonasal 11 44% 14 56% 12 48% 13 52%
GCIPL inferotemporal 15 60% 10 40% 16 64% 9 36%
Average 12.13 49% 12.88 52% 12.5 50% 12.5 50%
∗GCIPL (< or =): number of cases where the ganglion cell-inner plexiform layer thickness is lower than or equal to before surgery.
†GCIPL (>): number of cases where the ganglion cell-inner plexiform layer thickness is higher than before surgery.
Table 7: Quality measurement analysis between the preoperative and postoperative macular GCIPL thickness values performed by
semimanual segmentation.
𝑁 = 25
Postoperative (1m) Postoperative (6m)
GCIPL (< or =)∗ GCIPL (>)† GCIPL (< or =)∗ GCIPL (>)†
Average GCIPL thickness 13 52% 12 48% 14 56% 11 44%
Minimum GCIPL thickness 13 52% 12 48% 13 52% 12 48%
GCIPL superior 13 52% 12 48% 15 60% 10 40%
GCIPL inferior 14 56% 11 44% 16 64% 9 36%
GCIPL superonasal 15 60% 10 40% 14 56% 11 44%
GCIPL superotemporal 15 60% 10 40% 17 68% 8 32%
GCIPL inferonasal 12 48% 13 52% 12 48% 13 52%
GCIPL inferotemporal 13 52% 12 48% 16 64% 9 36%
Average 13.50 54% 11.50 46% 14.63 59% 10.38 42%
∗GCIPL (< or =): number of cases where the ganglion cell-inner plexiform layer thickness is lower than or equal to before surgery.
†GCIPL (>): number of cases where the ganglion cell-inner plexiform layer thickness is higher than before surgery.
concentration, time of tissue contact, and ILM mechanical
tractions [7].However, no visual field defects have been found
after BBG-assisted ILM removal [33].
The GCC color map provided by the RTVue software
may allow identifying specific areas of focal ganglion cell loss.
Actually, Baba et al. showed one case of a predominantly
temporal GCC loss in the color-coded GCC thickness map
reported [17].
On the other hand, we observed a significant decrease
in the MCAT and MCV at 6 months after surgery. Some
patients presented a preoperative abnormal increase of both
parameters, secondary to microcystic edema usually present
at the edge of the macular hole [34–36]. Additionally,
MCAT and MCV results may be affected significantly by
the positioning of the scanning beam in the pupil and the
resultant angle of incidence on the retina [37]. In fact, this
measurement error may be even more frequent when IMH is
present.
The study had some limitations. First, our series of
patients is relatively small, in part because the GCA software
of the Cirrus HD-OCT has only recently become commer-
cially available.Therefore, future studies should be performed
to validate our results. Second, longer observation periods are
needed in order to evaluate the GCIPL progress over time.
Third, the automatic segmentation performed by the GCA
software may be altered in some patients where the macular
morphology is distorted due to the IMH (Figure 3). Actually,
these measurement errors may be the reason why almost
no differences were found in the average GCIPL thickness
in our study. In fact, we observed that GCIPL thickness
analysis in some macular quadrants was higher after surgery
than before surgery, even if the analysis was performed by
automated or semimanual segmentation (Tables 6 and 7,
resp.). Therefore, additional studies should be performed in
order to determine the ability of the Cirrus HD-OCT (Carl
Zeiss Meditec, Dublin, CA) to analyze the GCIPL in patients
with different macular diseases. Alternatively, a real manual
segmentation could be performed by custom OCT analysis
software (i.e., OCTOR).
In conclusion, only focal temporal changes in the GCIPL
thickness may be appreciated after vitrectomy with BBG-
assisted ILM peeling for IMH. Furthermore, the results
provided by Cirrus HD-OCT (Carl Zeiss Meditec, Dublin,
CA) ganglion analysis software should be carefully evaluated
BioMed Research International 7
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Figure 3: Examples of scans with incorrect ganglion cell-inner plexiform layer segmentation due tomacular morphology distortion. (a) OCT
ganglion cell analysis in a patient after idiopathic macular hole surgery. (b) OCT ganglion cell analysis in a patient with an idiopathic macular
hole. The arrows show an area where the automated segmentation was incorrectly performed.
in patients with maculopathies where there is a macular
morphology distortion. However, semimanual segmentation
may slightly help to improve the quality of theGCIPL analysis
in these patients.
4. Conclusions
A significant reduction of GCIPL thickness at the temporal
macular quadrants was observed by SD-OCT analysis with
the new ganglion cell analysis (GCA) software of the Cirrus
HD-OCT (Carl Zeiss Meditec, Dublin, CA) at 6 months after
vitrectomy with BBG-assisted internal limiting membrane
removal for idiopathic macular hole surgery. This reduction
detection was higher when the analysis was performed by
semimanual segmentation. On the other hand, an increase
in the postoperative GCIPL thickness was observed in a
significant number of patients, although this increase was less
pronounced when the analysis was performed by semiman-
ual segmentation. As we assume that an increase in GCIPL
thickness is not expected after surgery, we hypothesize that
these values may be artefacts or even a subtle inner retinal
edema after ILM peeling, which could be caused by BBG
dye. In this study we have evaluated the capacity of the
new software of the Cirrus HD-OCT (Carl Zeiss Meditec,
Dublin, CA) to analyze changes in the retinal GCIPL after
internal limiting membrane peeling for idiopathic macular
hole surgery, but further studies should be performed in
patients with other frequent macular pathologies. To our
knowledge, no study has previously validated this software
in macular pathology. Glaucoma specialists must take into
consideration this possible bias in GCIPL thickness analysis
in patients with vitreomacular surface changes.
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